Inventor
AYRAL-KALOUSTIAN SEMIRAMIS
US33 patents
⚠️ This page may combine multiple inventors who share the name “AYRAL-KALOUSTIAN SEMIRAMIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WYETH CORP
14 patentsUS7524849B2Apr 28, 2009
5-arylpyrimidines as anticancer agents
WYETH CORP29 citations92
US7626023B2Dec 1, 2009
Compounds for treating tumors
WYETH CORP12 citations81
US7390910B2Jun 24, 2008
Compounds for treating tumors
WYETH CORP14 citations81
US6716862B2Apr 6, 2004
5-(Substituted)-5-(substitutedsulfonyl or sulfanyl) thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase
WYETH CORP3 citations60
US6784184B2Aug 31, 2004
5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase
WYETH CORP4 citations56
US6710078B2Mar 23, 2004
5-Substituted-3(2H)-furanones useful for inhibition of farnesyl-protein transferase
WYETH CORP3 citations56
US7915266B2Mar 29, 2011
6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents
WYETH CORP0 citations52
US7285555B2Oct 23, 2007
6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents
WYETH CORP0 citations52
US6949661B2Sep 27, 2005
3-substituted-3-(substitutedsulfonyl or sulfanyl) pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase
WYETH CORP0 citations52
US6861445B2Mar 1, 2005
3-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase
WYETH CORP0 citations52
US6740675B2May 25, 2004
3-substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase
WYETH CORP0 citations52
US7507739B2Mar 24, 2009
6-[(substituted)phenyl]triazolopyrimidines as anticancer agents
WYETH CORP0 citations41
US7396835B2Jul 8, 2008
Process for the preparation of tubulin inhibitors
WYETH CORP0 citations39
US6605628B1Aug 12, 2003
Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase
WYETH CORP0 citations35
AMERICAN CYANAMID CO
10 patentsUS5312831AMay 17, 1994
Urethanes and ureas that induce cytokine production
AMERICAN CYANAMID CO48 citations95
US4968790ANov 6, 1990
Antidiabetic phosphates
AMERICAN CYANAMID CO33 citations92
US6403581B1Jun 11, 2002
Method of inhibition of farnesyl-protein transferase using substituted benz (cd) indol-2-imine and-amine derivatives
AMERICAN CYANAMID CO56 citations89
US5658945AAug 19, 1997
Urethanes and ureas that induce cytokine production
AMERICAN CYANAMID CO7 citations73
US5633280AMay 27, 1997
Urethanes and ureas that induce cytokine production
AMERICAN CYANAMID CO4 citations73
US5616612AApr 1, 1997
Urethanes and ureas that enhance the growth of bone marrow progenitor cells
AMERICAN CYANAMID CO8 citations73
US4945158AJul 31, 1990
Antidiabetic phosphonates
AMERICAN CYANAMID CO7 citations73
US4943629AJul 24, 1990
Antidiabetic alpha-substituted phosphonates
AMERICAN CYANAMID CO11 citations73
US5545662AAug 13, 1996
Urethanes and ureas that induce cytokine production
AMERICAN CYANAMID CO1 citations62
US5602275AFeb 11, 1997
Urethanes and ureas that induce cytokine production
AMERICAN CYANAMID CO0 citations51
WYETH LLC
5 patentsUS8748421B2Jun 10, 2014
Triazine compounds as P13 kinase and MTOR inhibitors
WYETH LLC11 citations92
US8039469B2Oct 18, 2011
Triazine compounds as PI3 kinase and mTOR inhibitors
WYETH LLC15 citations91
US7713994B2May 11, 2010
Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof
WYETH LLC27 citations88
US8859542B2Oct 14, 2014
Triazine compounds as PI3 kinase and mTOR inhibitors
WYETH LLC9 citations83
US10022381B2Jul 17, 2018
Triazine compounds as PI3 kinase and mTOR inhibitors
WYETH LLC5 citations72